HOME PAGE  

 REQUEST A FREE CONSULTATION

 
  Aneuploidy Screening

<<

BACK

 
  Preimplantation genetic aneuploidy screening (PGS) has been performed as a way of enhancing embryo selection in patients with an increased incidence of embryonic numerical chromosome abnormalities (advanced maternal age, recurrent miscarriage and recurrent implantation failure). It has been proposed that the replacement of euploid embryos in these patients would result in a higher implantation and pregnancy rate and a reduced miscarriage rate. Additionally, the transfer of fewer embryos could reduce the chances for multiple pregnancies in all IVF patients. Although, to date, multiple studies have addressed this issue, contradictory results have been encountered. As a result, the effectiveness of aneuploidy screening remains to be established. Moreover, child outcome studies documenting the safety of this procedure are needed.

For couples aware of genetic disorders through family history or based on carrier testing, PGD testing can be performed to help avoid a pregnancy or child born with the specified genetic condition. In genetic disorders where the gene structure is known, such as Cystic Fibrosis or Tay-Sachs, the actual genes of the embryo are examined for presence of the condition. Other genetic disorders, such as Duchenne muscular dystrophy or hemophilia, only affect males and, therefore, the DNA of the embryo is examined to determine the sex and only the female embryos are transferred.

PGS can currently be used to detect the following single gene disorders:
 
  • Cystic Fibrosis
  • Sickle Cell Anemia
  • Thalassemia
  • Tay Sachs Disease
  • Myotonic Dystrophy
  • Fragile X Syndrome
  • Phenylketonuria (PKU)
  • Gaucher's Disease
  • Retinoblastoma
  • Hemophilia
  • ADA Deficiency
  • Multiple Epiphyseal Dysplasia
  • Fanconi Anemia
  • Alzheimer’s
  • Retinitis Pigmentosa
  • Epidermolysis Bullosa
  • Duchenne's muscular dystrophy
  • OTC Deficiency
  • Achondroplasis
  • LCHAD
  • X-Linked Hydrocephalus
 

 REQUEST A FREE CONSULTATION
 
     
 

   FERTILITY TREATMENT OPTIONS

FERTILITY TREATMENTS
Fertility treatment options that are result driven and affordable.
GENETIC SCREENING
PGD involves carefully removing one or more cells from an embryo for analysis.
GENDER SELECTION
PGD Gender Selection is a procedure that enables couples to choose the sex of their baby.
CRYOPRESERVATION
Egg freezing program for women who are planning to use their own eggs in the future.
PATIENT GUIDE
There are many things you should know about before embarking on a journey. 
 
QUESTIONS OR COMMENTS ON BANGKOK FERTILITY ?
CALL +66(0)83 535 1619, Fax: +66(0)2 9240734
WRITE 77/4 The Emerald Garden village, Leab Klong-Ann Rd., Bangplub, Pakgred, Noothaburi, 11120, Thailand
E-MAIL consult@bangkokfertility.com
 

© Prime Health Co., Ltd. 2007 - 2010. All Rights Reserved.